Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
20h
FDA approves Ebglyss for moderate-to-severe atopic dermatitis
The U.S. Food and Drug Administration has approved Eli Lilly's Ebglyss (lebrikizumab-lbkz) for adults and children aged 12 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Kentucky judge fatally shot
Makes MLB history
Cancels appearance w/ Duda
Boy kills bear, saves father
To get a second moon
Ban called for in TX schools
Los Angeles dengue cases
Families lose appeal
30 yrs in prison for assault
Joins Motion Picture Assn.
Collapse hazard recall
Overdose deaths drop in US
Gun case sentencing delay
US healthcare system falls
Deal to build new arena
Retaliated against scientists
AC mayor, wife indicted
Man charged for threats
UN backs Palestine
NYC subway joyride arrest
To receive Holbrooke award
Brazil threatens daily fines
US jobless claims fall
FTC on privacy controls
Vows to remain in race
Hails economic progress
EU warns Apple
COVID, Wuhan market link
Retires after 17 seasons
Rally attendees injured
Existing home sales drop
Dow, S&P hit record highs
160M euros to Ukraine
Related topics
Lilly
England
United States
Atopic dermatitis
snooker
Feedback